Merck to Acquire EyeBio - Merck merck.com Submitted by merckcom3067 on May 31, 2024 at 6:02 AM in business No comments 13
Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results - Merck merck.com Submitted by merckcom3067 on February 2, 2024 at 11:30 AM in business No comments 3
Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline - Merck merck.com Submitted by merckcom3067 on January 9, 2024 at 12:30 PM in business No comments 45
Merck to Acquire Caraway Therapeutics, Inc. - Merck merck.com Submitted by merckcom3067 on November 22, 2023 at 11:45 AM in business No comments 1
KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival (OS) Versus Placebo as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Nephrectomy - Merck merck.com Submitted by merckcom3067 on November 2, 2023 at 11:30 AM in business No comments 23
Merck Announces Third-Quarter 2023 Financial Results - Merck merck.com Submitted by merckcom3067 on October 27, 2023 at 10:30 AM in business No comments 59
Daiichi Sankyo and Merck Announce Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs - Merck merck.com Submitted by merckcom3067 on October 20, 2023 at 11:30 PM in business No comments 58
Merck Announces Pivotal KEYNOTE-671 Trial Meets Dual Primary Endpoint of Overall Survival (OS) in Resectable Stage II, IIIA or IIIB Non-Small Cell Lung Cancer (NSCLC) - Merck merck.com Submitted by merckcom3067 on October 11, 2023 at 10:30 AM in business No comments 36
Merck's KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Muscle-Invasive Urothelial Carcinoma (MIUC) After Surgery - Merck merck.com Submitted by merckcom3067 on October 6, 2023 at 11:00 AM in business No comments 57
Merck Announces WELIREG® (belzutifan) Phase 3 LITESPARK-005 Trial Met Primary Endpoint of Progression-Free Survival in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma - Merck merck.com Submitted by merckcom3067 on August 18, 2023 at 10:45 AM in business No comments 40
Merck Announces Second-Quarter 2023 Financial Results - Merck merck.com Submitted by merckcom3067 on August 1, 2023 at 10:30 AM in business No comments 54